REAX Stock Analysis: Real Brokerage | NASDAQ
Real Estate Services | NASDAQ, USA | Market Cap: 407m USD | 12M Return: -60.3% | CA75585H2063 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.8M
Qual. Beats: -1
Rev. Trend: 99.1%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 6.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Real Brokerage Inc. (REAX) is a real estate technology company operating in the United States and Canada, founded in 2014 and headquartered in Miami, Florida. The company provides title, mortgage, and wallet services, along with ancillary offerings such as mortgage origination, title and escrow services, and financial technology and lending products. As a PropTech-focused firm, REAX operates within the real estate sector and aims to streamline traditional brokerage transactions through an integrated, tech-enabled platform that combines agent services with adjacent financial products typically handled by separate providers at closing.
- Agent count growth accelerates transaction volume expansion
- NAR settlement reshapes real estate commission economics
- Title and mortgage services lift per-transaction revenue
| Net Income: -16.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.29 > 0.02 and ΔFCF/TA -3.58 > 1.0 |
| NWC/Revenue: 2.65% < 20% (prev 1.80%; Δ 0.85% < -1%) |
| CFO/TA 0.42 > 3% & CFO 89.9m > Net Income -16.1m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.0m) vs 12m ago -90.13% < -2% |
| Gross Margin: 8.23% > 18% (prev 8.90%; Δ -0.67% > 0.5%) |
| Asset Turnover: 1.23k% > 50% (prev 1.08k%; Δ 152.0% > 0%) |
| Interest Coverage Ratio: -16.20 > 6 (EBIT TTM -15.2m / Interest Expense TTM 937k) |
| A: 0.28 (Total Current Assets 194.1m - Total Current Liabilities 134.8m) / Total Assets 213.4m |
| B: -0.58 (Retained Earnings -124.3m / Total Assets 213.4m) |
| C: -0.08 (EBIT TTM -15.2m / Avg Total Assets 181.4m) |
| D: 0.58 (Book Value of Equity 78.7m / Total Liabilities 134.8m) |
| Altman-Z'' = -0.03 = B |
| DSRI: 1.20 (Receivables 44.9m/26.9m, Revenue 2.24b/1.62b) |
| GMI: 1.08 (GM 8.90% / 8.23%) |
| AQI: 0.68 (AQ_t 0.08 / AQ_t-1 0.12) |
| SGI: 1.38 (Revenue 2.24b / 1.62b) |
| TATA: -0.50 (NI -16.1m - CFO 89.9m) / TA 213.4m) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of September 16, 2026, the stock is trading at USD 20.28 with a total of 691,922 shares traded. Over the past week, the price has changed by +10.22%, over one month by -11.83%, over three months by +27.55% and over the past year by -60.31%.
Current recommended Stop Loss: 17.60 (which is 13.2% or 1.3 ATR below the current price).
Real Brokerage has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy REAX.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 49.5 | 144.1% |
P/S = 0.1817
P/B = 4.9887
Revenue TTM = 2.24b USD
EBIT TTM = -15.2m USD
EBITDA TTM = -12.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 328.2m USD (406.9m + (null Debt) - CCE 78.7m)
Interest Coverage Ratio = -16.20 (Ebit TTM -15.2m / Interest Expense TTM 937k)
EV/FCF = 5.29x (Enterprise Value 328.2m / FCF TTM 62.0m)
FCF Yield = 18.89% (FCF TTM 62.0m / Enterprise Value 328.2m)
FCF Margin = 2.77% (FCF TTM 62.0m / Revenue TTM 2.24b)
Net Margin = -0.72% (Net Income TTM -16.1m / Revenue TTM 2.24b)
Gross Margin = 8.23% ((Revenue TTM 2.24b - Cost of Revenue TTM 2.06b) / Revenue TTM)
Gross Margin QoQ = 8.32% (prev 9.05%)
Tobins Q-Ratio = 1.54 (Enterprise Value 328.2m / Total Assets 213.4m)
Interest Expense / Debt = unknown (Interest Expense 937k / Debt none)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -12.0m (EBIT -15.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.43 (Total Current Assets 194.1m / Total Current Liabilities 135.7m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA -12.9m)
Debt / FCF = unknown (Net Debt none / FCF TTM 62.0m)
Total Stockholder Equity = 62.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.87% (Net Income -16.1m / Total Assets 213.4m)
RoE = -25.78% (Net Income TTM -16.1m / Total Stockholder Equity 62.4m)
RoCE = -19.31% (EBIT -15.2m / Capital Employed (Total Assets 213.4m - Current Liab 134.8m))
RoIC = 12.6k% (out of range, set to none) (NOPAT -12.0m / Invested Capital -95.0k)
WACC = 9.75% (E(406.9m)/V(406.9m) * Re(9.75%) + (debt-free company))
Discount Rate = 9.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -53.31 | Cagr: -60.36%
[DCF] Terminal Value 73.58% ; FCFF base≈56.7m ; Y1≈65.0m ; Y5≈95.7m
[DCF] Fair Price = 52.96 (EV 1.15b - Net Debt 0.0 = Equity 1.15b / Shares 21.8m; r=9.75% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -4.0 | # QB: -1
Revenue Correlation: 99.14 | Revenue CAGR: 64.08% | SUE: 1.63 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.08 | Chg30d=+6.67% | Revisions=+0% | Analysts=5
EPS current Year (2026-12-31): EPS=-0.46 | Chg30d=-130.00% | Revisions=-40% | GrowthEPS=-15.0% | GrowthRev=+30.5%
EPS next Year (2027-12-31): EPS=0.40 | Chg30d=+166.67% | Revisions=+40% | GrowthEPS=+187.0% | GrowthRev=+21.3%
[Analyst] Revisions Ratio: +0% (up=2, down=2)